{"id":"NCT05357989","sponsor":"Annovis Bio Inc.","briefTitle":"A Double-blind Study to Investigate Efficacy and Safety of Buntanetap Compared With Placebo in Participants With Early PD","officialTitle":"A 6-month Prospective, Randomized, Double-blind, Placebo-controlled Clinical Trial Investigating the Efficacy, Safety, and Tolerability of Two Different Doses of Buntanetap or Placebo in Patients With Early Parkinson's Disease","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2022-08-03","primaryCompletion":"2023-12-04","completion":"2023-12-04","firstPosted":"2022-05-03","resultsPosted":"2025-03-03","lastUpdate":"2025-03-03"},"enrollment":523,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Parkinson's Disease, Idiopathic"],"interventions":[{"type":"DRUG","name":"buntanetap/posiphen","otherNames":["Posiphen Tartrate","ANVS401"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"10 mg buntanetap/posiphen","type":"EXPERIMENTAL"},{"label":"20 mg buntanetap/posiphen","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to measure safety and efficacy of buntanetap/posiphen capsules compared with placebo capsules in participants with early PD.\n\nStudy details include:\n\n* The study duration will be up to 7-8 months.\n* The double-blind treatment duration will be up to 6 months.\n* There will be 5 in-clinic visits and 7 phone calls","primaryOutcome":{"measure":"Change From Baseline to Month 6 in MDS-UPDRS Part II (OFF-state)","timeFrame":"Baseline and 6 months visits","effectByArm":[{"arm":"Placebo","deltaMin":-0.1,"sd":0.311},{"arm":"10 mg Buntanetap/Posiphen","deltaMin":0.57,"sd":0.312},{"arm":"20 mg Buntanetap/Posiphen","deltaMin":-0.04,"sd":0.319}],"pValues":[]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":69,"countries":["United States","Germany","Hungary","Italy","Poland","Spain"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":176},"commonTop":["Nausea","Covid-19","Fatigue"]}}